ERBB2 and breast cancer: We analyzed the endogenous expression levels of ETV7 among a panel of breast cancer cell lines and we observed a higher expression of ETV7 protein in triple negative and HER2+-derived cell lines, compared to the luminal ones, suggesting a correlation between the expression of ETV7 and the aggressiveness of the tumor (Supplementary Fig. 1A).